Stereospecific targeting of MTH1 by (S)-crizotinib as an anticancer strategy KVM Huber, E Salah, B Radic, M Gridling, JM Elkins, A Stukalov, ... Nature 508 (7495), 222-227, 2014 | 442 | 2014 |
The solute carrier SLC35F2 enables YM155-mediated DNA damage toxicity GE Winter, B Radic, C Mayor-Ruiz, VA Blomen, C Trefzer, RK Kandasamy, ... Nature chemical biology 10 (9), 768-773, 2014 | 175 | 2014 |
Heme drives hemolysis-induced susceptibility to infection via disruption of phagocyte functions R Martins, J Maier, AD Gorki, KVM Huber, O Sharif, P Starkl, S Saluzzo, ... Nature immunology 17 (12), 1361-1372, 2016 | 132 | 2016 |
The YAP/TAZ pathway in osteogenesis and bone sarcoma pathogenesis H Kovar, L Bierbaumer, B Radic-Sarikas Cells 9 (4), 972, 2020 | 87 | 2020 |
The second European interdisciplinary Ewing sarcoma research summit–A joint effort to deconstructing the multiple layers of a complex disease H Kovar, J Amatruda, E Brunet, S Burdach, F Cidre-Aranaz, E De Alava, ... Oncotarget 7 (8), 8613, 2016 | 52 | 2016 |
YAP/TAZ inhibition reduces metastatic potential of Ewing sarcoma cells L Bierbaumer, AM Katschnig, B Radic-Sarikas, MO Kauer, JA Petro, ... Oncogenesis 10 (1), 2, 2021 | 39 | 2021 |
Lapatinib potentiates cytotoxicity of YM155 in neuroblastoma via inhibition of the ABCB1 efflux transporter B Radic-Sarikas, M Halasz, KVM Huber, GE Winter, KP Tsafou, ... Scientific Reports 7 (1), 3091, 2017 | 38 | 2017 |
The class I-specific HDAC inhibitor MS-275 modulates the differentiation potential of mouse embryonic stem cells G Franci, L Casalino, F Petraglia, M Miceli, R Menafra, B Radic, V Tarallo, ... Biology open 2 (10), 1070-1077, 2013 | 26 | 2013 |
Histone deacetylase inhibitors: clinical implications for hematological malignancies FP Tambaro, C Dell’Aversana, V Carafa, A Nebbioso, B Radic, F Ferrara, ... Clinical epigenetics 1, 25-44, 2010 | 26 | 2010 |
Combinatorial drug screening identifies Ewing sarcoma–specific sensitivities B Radic-Sarikas, KP Tsafou, KB Emdal, T Papamarkou, KVM Huber, ... Molecular Cancer Therapeutics 16 (1), 88-101, 2017 | 21 | 2017 |
Identifying the druggable interactome of EWS-FLI1 reveals MCL-1 dependent differential sensitivities of Ewing sarcoma cells to apoptosis inducers K Tsafou, AM Katschnig, B Radic-Sarikas, CN Mutz, K Iljin, R Schwentner, ... Oncotarget 9 (57), 31018, 2018 | 12 | 2018 |
Zooming in on long non-coding RNAs in ewing sarcoma pathogenesis DNT Aryee, V Fock, U Kapoor, B Radic-Sarikas, H Kovar Cells 11 (8), 1267, 2022 | 5 | 2022 |
High-content drug screening in zebrafish xenografts reveals high efficacy of dual MCL-1/BCL-XL inhibition against Ewing sarcoma S Grissenberger, C Sturtzel, A Wenninger-Weinzierl, B Radic-Sarikas, ... Cancer Letters 554, 216028, 2023 | 4 | 2023 |
Enhancing cognate target elution efficiency in gel-free chemical proteomics B Radic-Sarikas, U Rix, A Stukalov, M Gridling, AC Müller, J Colinge, ... EuPA Open Proteomics 9, 43-53, 2015 | 2 | 2015 |
Targeting YAP/TAZ pathway inhibits Ewing sarcoma metastasis L Bierbaumer, AM Katschnig, B Radic-Sarikas, JR Petro, K Mühlbacher, ... Cancer Research 79 (13_Supplement), 1049-1049, 2019 | 1 | 2019 |
In vitro modeling of pediatric solid tumor lung metastases M Zylka, C Hafemeister, L Watzke, U Mann, D Surdez, EA Sweet-Cordero, ... Cancer Research 84 (6_Supplement), 196-196, 2024 | | 2024 |
3D-models of pediatric bone sarcomas for personalized therapeutic screening B Radic Sarikas, M Ilg, M Markovic, C Sturtzel, E Scheuringer, J Zulini, ... # PLACEHOLDER_PARENT_METADATA_VALUE# 82, 2022 | | 2022 |
3D-models of pediatric bone sarcomas for personalized therapeutic screening BR Sarikas, M Ilg, M Markovic, C Sturtzel, E Scheuringer, J Zulini, ... Cancer Research 82 (12_Supplement), 6245-6245, 2022 | | 2022 |
Targeted Therapy H Gad, T Koolmeister, AS Jemth, S Eshtad, SA Jacques, CE Ström, ... cancer strategy 508, 222-7, 2014 | | 2014 |
Elucidating the molecular mechanism of action of cancer drugs in the second decade of the new millennium G Superti-Furga, G Winter, J Bigenzahn, B Radic, J Colinge, K Bennett, ... Experimental Hematology 41 (8), S9, 2013 | | 2013 |